Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Clinical Study Of EYE001 In Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

This study will examine the efficacy and safety of pegaptanib sodium in Japanese patients with wet-type AMD, in order to establish that there is no large difference in the efficacy and the safety of the drug between Western and Japanese patients.

Inclusion Criteria:

• Wet AMD, Visual Acuity from 20/320 to 20/40

Exclusion Criteria:

• Diabetic retinopathy, laser coagulation history